Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,654 | 101,832 | 61,353 | 66,641 | 29,723 |
| Marketable Securities | 139,741 | 16,055 | 66,732 | 72,229 | 54,172 |
| Receivables | 4,823 | N/A | N/A | N/A | N/A |
| Other current assets | 401 | 174 | 548 | 325 | 463 |
| TOTAL | $213,855 | $120,257 | $129,756 | $140,003 | $85,552 |
| Non-Current Assets | |||||
| PPE Net | 2,150 | 1,419 | 1,108 | 858 | 773 |
| Investments And Advances | 5,085 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 677 | 724 | 811 | 872 | 597 |
| TOTAL | $7,912 | $2,143 | $1,919 | $1,730 | $1,370 |
| Total Assets | $221,767 | $122,400 | $131,675 | $141,733 | $86,922 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,015 | N/A | 0 | 5,607 |
| Accounts payable and accrued liabilities | 1,943 | 2,404 | 2,126 | 4,592 | 3,994 |
| Accrued Expenses | 2,938 | 2,653 | 3,345 | 880 | 999 |
| TOTAL | $51,702 | $6,072 | $5,470 | $5,471 | $10,601 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 11,827 | 12,833 | 12,186 | 7,922 |
| Deferred Revenues | 46,809 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 638 | 638 |
| TOTAL | $70,224 | $11,827 | $12,833 | $12,824 | $8,560 |
| Total Liabilities | $121,926 | $17,900 | $18,303 | $18,295 | $19,161 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,871 | 35,837 | 35,793 | 35,738 | 35,568 |
| Common Shares | 36 | 36 | 36 | 36 | 30 |
| Retained earnings | -153,804 | -148,371 | -138,601 | -127,847 | -115,777 |
| Other shareholders' equity | -50 | -2 | -6 | 14 | 30 |
| TOTAL | $99,841 | $104,500 | $113,372 | $123,438 | $67,761 |
| Total Liabilities And Equity | $221,767 | $122,400 | $131,675 | $141,733 | $86,922 |